196 related articles for article (PubMed ID: 1886490)
1. Comparison of serological and chemical characteristics of capsular polysaccharides of Cryptococcus neoformans var. neoformans serotype A and Cryptococcus albidus var. albidus.
Ikeda R; Matsuyama H; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1991; 35(2):125-38. PubMed ID: 1886490
[TBL] [Abstract][Full Text] [Related]
2. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D.
Ikeda R; Nishikawa A; Shinoda T; Fukazawa Y
Microbiol Immunol; 1985; 29(10):981-91. PubMed ID: 3908888
[TBL] [Abstract][Full Text] [Related]
3. Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.
Small JM; Mitchell TG; Wheat RW
Infect Immun; 1986 Dec; 54(3):735-41. PubMed ID: 3536746
[TBL] [Abstract][Full Text] [Related]
4. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
Bacon BE; Cherniak R; Kwon-Chung KJ; Jacobson ES
Carbohydr Res; 1996 Mar; 283():95-110. PubMed ID: 8901265
[TBL] [Abstract][Full Text] [Related]
5. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
Ikeda R; Maeda T
Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387
[TBL] [Abstract][Full Text] [Related]
6. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.
Ikeda R; Shinoda T; Fukazawa Y; Kaufman L
J Clin Microbiol; 1982 Jul; 16(1):22-9. PubMed ID: 6179964
[TBL] [Abstract][Full Text] [Related]
7. The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D.
Bhattacharjee AK; Kwon-Chung KJ; Glaudemans CP
Carbohydr Res; 1979 Aug; 73():183-92. PubMed ID: 113098
[TBL] [Abstract][Full Text] [Related]
8. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
[TBL] [Abstract][Full Text] [Related]
9. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.
Small JM; Mitchell TG
Infect Immun; 1989 Dec; 57(12):3751-6. PubMed ID: 2680980
[TBL] [Abstract][Full Text] [Related]
10. [Mycological and serological diagnosis of cryptococcosis].
Ikeda R; Shinoda T
Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):241-4. PubMed ID: 11064322
[TBL] [Abstract][Full Text] [Related]
11. Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.
Small JM; Mitchell TG
Infect Immun; 1986 Dec; 54(3):742-50. PubMed ID: 3536747
[TBL] [Abstract][Full Text] [Related]
12. Capsular polysaccharides of Cryptococcus neoformans.
Bhattacharjee AK; Bennett JE; Glaudemans CP
Rev Infect Dis; 1984; 6(5):619-24. PubMed ID: 6209768
[TBL] [Abstract][Full Text] [Related]
13. Distribution of the O-acetyl groups and β-galactofuranose units in galactoxylomannans of the opportunistic fungus Cryptococcus neoformans.
Previato JO; Vinogradov E; Maes E; Fonseca LM; Guerardel Y; Oliveira PAV; Mendonça-Previato L
Glycobiology; 2017 Jun; 27(6):582-592. PubMed ID: 27986834
[TBL] [Abstract][Full Text] [Related]
14. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.
Cherniak R; Morris LC; Belay T; Spitzer ED; Casadevall A
Infect Immun; 1995 May; 63(5):1899-905. PubMed ID: 7729900
[TBL] [Abstract][Full Text] [Related]
15. Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay.
Belay T; Cherniak R; Shinoda T
Infect Immun; 1993 Jul; 61(7):2879-85. PubMed ID: 7685739
[TBL] [Abstract][Full Text] [Related]
16. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.
Cherniak R; Reiss E; Slodki ME; Plattner RD; Blumer SO
Mol Immunol; 1980 Aug; 17(8):1025-32. PubMed ID: 6777664
[No Abstract] [Full Text] [Related]
17. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy.
Bacon BE; Cherniak R
Carbohydr Res; 1995 Oct; 276(2):365-86. PubMed ID: 8542606
[TBL] [Abstract][Full Text] [Related]
18. Anti-chemotactic activity of capsular polysaccharide of Cryptococcus neoformans in vitro.
Fujihara H; Kagaya K; Fukazawa Y
Microbiol Immunol; 1997; 41(9):657-64. PubMed ID: 9343815
[TBL] [Abstract][Full Text] [Related]
19. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
Belay T; Cherniak R
Infect Immun; 1995 May; 63(5):1810-9. PubMed ID: 7537249
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic fractions of Cryptococcus neoformans.
Graybill JR; Straus DC; Nealon TJ; Hague M; Paque RE
Mycopathologia; 1982 Apr; 78(1):31-9. PubMed ID: 7048099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
